MOMENTUM-1: a multicenter, randomized, open-label, phase 2 study of [177Lu]Lu-DOTA-TATE in adults with progressive grade 1-3 meningioma (RTOG 3523) Article Other Scholarly Work

Kurz, Sylvia C, Rabbee, Nusrat, Wen, Patrick Y et al. (2025). MOMENTUM-1: a multicenter, randomized, open-label, phase 2 study of [177Lu]Lu-DOTA-TATE in adults with progressive grade 1-3 meningioma (RTOG 3523) . Neuro-Oncology, 27 v423-v422. 10.1093/neuonc/noaf201.1671

Open Access

cited authors

  • Kurz, Sylvia C; Rabbee, Nusrat; Wen, Patrick Y; Kalapurakal, John A; Peereboom, David M; Bi, Linda W; Huang, Raymond; Ivanidze, Jana; Perry, Arie; Cahill, Jennifer; Johnson, Derek R; Mehta, Minesh; Sulman, Erik P

authors

publication date

  • November 1, 2025

published in

keywords

  • 3 Good Health and Well Being
  • 3202 Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • 6.1 Pharmaceuticals
  • Biomedical Imaging
  • Clinical Neurology
  • Clinical Trials and Supportive Activities
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • Orphan Drug
  • Patient Safety
  • Science & Technology

Digital Object Identifier (DOI)

start page

  • v423

end page

  • v422
  • v423

volume

  • 27